my analysis of today's event, page-3

Roger10 that would be against all ASX non-disclosure rules to appoint someone from a company that intends to takeover ACL.

I will miss Charles he was a decent person, an honest CEO and he had a healthy, respectful consideration for the owners of ACL.

That aside, The trial which we are all interested in should have finalised last OCTOBER, here we are in FEBRUARY with no data lock in which to assess the trial outcomes, I’m Impressed.

I will worry if Tracy Brown resigns, personally I hope her lifelong ambition to improve quality of life and longevity of victims of cancer will be successful, if it is she will be up there with the likes of Lord Howard Florey and Ian Frazer.

I would of pulled the Audeo S1 anyway, if you are going to do, do it as ACL,
The benefits to ACL are:
1. 10+ years of history of ACL not a fly by night San Fran Company
2. Fonda Income and reputation for getting a drug 2 market
3. Don't have to pay two Boards
4. Dual Listing is a better way
5. Successful Phase III at the time
6. Tax Implications resides with ACL less to pay until past loses are taken to account.
7. R&D rebate less complicated.
8. Less paperwork
9. Going to sign a deal anyway